MAIA

Maia Biotechnology Inc
4.45
-0.28 (-5.92%)

MAIA Biotechnology Inc. (MAIA) Fundamentals

MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
SHARE INFORMATION
Market Cap$ 51,774,126
Shares Outstanding10,945,904
Float7,520,317
Percent Float68.7%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.18
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions14
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent2.2%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months61,295
Insider Holdings Percent25.6
Insider Sold Previous 3 Months10,000
Insider Shares Owned2,805,535
TRADING INFO
52 Week High$ 9.64
52 Week Low$ 3.10
52 Week High Change$ 0.00
21 Day Moving Average$ 4.2743
21 Day Extended Moving Average$ 4.2997
50 Day Moving Average$ 3.8039
50 Day Extended Moving Average$ 3.9835
200 Day Moving Average$ 3.8596
200 Day Extended Moving Average$ 3.9942
10 Day Average Volume15,768
20 Day Average Volume27,046
30 Day Average Volume22,084
50 Day Average Volume18,385
Alpha-0.013838
Beta2.3215
Standard Deviation0.224464
R20.579382
7 Day Price Change$ 0.245
7 Day Percent Change5.46%
21 Day Price Change$ 0.74
21 Day Percent Change18.55%
30 Day Price Change$ 1.19
30 Day Percent Change33.62%
Month to Date Price Change$ 0.04
Month to Date Percent Change0.85%
Quarter to Date Price Change$ 1.22
Quarter to Date Percent Change34.76%
180 Day Price Change$ -0.63
180 Day Percent Change-11.75%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 1.22
Year to Date Percent Change34.76%

MAIA Biotechnology Inc. (MAIA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.20
Total Debt To Equity0.00
Int Coverage-7,441.30
Current Ratio6.00
Leverage Ratio1.30
Quick Ratio5.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.30
Enterprise Value$ 51,574,422
Price to Sales0.00
Price to Free Cash-5.70
PE High Last 5 Years0.00
Price To Book4.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-102.11
Return on Equity-122.46
Return on Capital-122.46

MAIA Biotechnology Inc. (MAIA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorEisnerAmper LLP
CEO-
Emplyoees12
Last AuditUE
CIK0001878313
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address444 West Lake Street
Suite 1700
Chicago, IL 60606
Websitehttps://www.maiabiotech.com
Facsimile-
Telephone+1 312 416-8592
Email-


Your Recent History
AMEX
MAIA
Maia Biote..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.